Exploring how diet and supplements can alleviate aromatase inhibitor-induced arthralgia and improve quality of life for breast cancer patients. Emerging research reveals how targeted nutritional inter...
New research highlights konjac glucomannan’s potential in weight management and metabolic health through gut microbiota modulation and SCFA production. Recent studies demonstrate konjac glucoman...
A 12-week TRE protocol (6h window) is being tested for early Huntington’s Disease, showing potential benefits for mitochondrial function and autophagy with 80% adherence expected. New clinical t...
Recent studies highlight dietary interventions like omega-3 fatty acids and vitamin D for managing aromatase inhibitor-induced arthralgia in ER+ breast cancer patients. New research supports dietary i...
New research reveals how modified forms of konjac glucomannan differentially impact glucose and lipid metabolism in obesity through gut microbiota alterations. Cutting-edge studies demonstrate konjac ...
New research shows personalized diets and targeted supplements significantly improve outcomes for breast cancer patients undergoing endocrine therapy, reducing side effects and enhancing quality of li...
Emerging research suggests time-restricted feeding may improve symptoms and slow neurodegeneration in Huntington’s disease through circadian rhythm synchronization and enhanced autophagy. New cl...
Recent studies highlight the efficacy of Mediterranean and plant-based diets, omega-3s, and vitamin D in mitigating side effects of aromatase inhibitors in breast cancer patients. Emerging research re...
Exploring how konjac glucomannan and other prebiotics influence weight through gut-brain communication, with insights from recent studies and practical dietary strategies. Recent research reveals how ...
Recent research reveals how intermittent fasting protocols interact with circadian rhythms to improve insulin sensitivity, gut microbiome diversity, and metabolic markers beyond weight loss. Emerging ...
